Analysts think PLUR stock price could increase by 120%
Jul 09, 2025, 11:25 AM
-9.96%
What does PLUR do
Pluri, formerly Pluristem Therapeutics Inc., is an IL-based biotechnology company focused on cell-based products for pharmaceuticals, food technology, and agriculture, with over 140 patents across 52 countries. Their research includes cell transformation technologies and therapeutic programs for various medical conditions.
3 analysts think PLUR stock price will increase by 119.75%. The current median analyst target is $12.24 compared to a current stock price of $5.57. The lowest analysts target is $12.12 and the highest analyst target is $12.60.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.